Despite a relatively light earnings calendar, the upcoming week features a diverse lineup of notable reports across ...
It turns out that the answer was no: Your dog’s genes don’t predict its behavior, at least not in the simplistic way popular doggy DNA tests often claim.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the ...
Levi & Korsinsky, LLP notifies investors in Synopsys, Inc. ("Synopsys, Inc." or the "Company") of a class action securities ...
Besides Wall Street's top-and-bottom-line estimates for Synopsys (SNPS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...
Nvidia is also thinking about a strategy that would take several years and cost up to $100 billion to buy OpenAI shares.
If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss ...
The Gross Law Firm issues the following notice to shareholders of Synopsys, Inc. . Shareholders who purchased shares of SNPS during ...
Synopsys is rated Hold with a $475 price target, reflecting a 10% upside and market-like performance amid premium valuation ...
Dr. Liz Peterson I started working as a doctor in 1981. Back then, I helped children learn lifelong healthy habits — such as brushing their teeth, wearing seat belts and eating good food. I believed ...
This investment serves a strategic purpose, aimed at enhancing the existing partnership between the two firms to advance ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, both dates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback